كلية الطب البشري

المزيد ...

حول كلية الطب البشري

لقد تم تأسيس كلية الطب البشري في سنة 1973م، بمدينة طرابلس لتقوم بدورها المنوط بها والمتمثل في تخريج الكوادر الطبية المؤهلة، وفي سنة 1980م تم تخريج أول دفعة منها.

تعد كلية الطب البشري من أكبر كليات الجامعة وصرحاً من صروح المعرفة، بحيث أسهمت هذه الكلية خلال العقود الأربعة الماضية في إعداد وتخريج أطباء مؤهلين كان لهم الفضل بعد الله تعالى في إنجاح العمل الطبي من خلال المستشفيات المنتشرة في ربوع الوطن الحبيب لتقديم أفضل الخدمات الصحية، تضم كلية الطب البشري حالياً أكثر من 493 عضو هيئة تدريس جُلهم من العناصر الوطنية الذين كانوا من أوائل الدفعات في هذه الكلية والذين ساهموا في تقديم الخدمات الصحية اللازمة في المستشفيات والعيادات والمستوصفات.

قد تم إيفاد العديد من خريجي هذه الكلية لاستكمال دراستهم في الخارج والذين أثبتوا جدارتهم في التحصيل العلمي والسريري بشهادة العديد من الجامعات العالمية، هذا وفي الوقت الذي تسعي فيه الكلية لتفعيل برنامج الدراسات العليا في مختلف التخصصات فإنها تعمل علي تطوير مفردات مناهجها وطرق التدريس المواكبة لمتطلبات الجودة العالمية.

حقائق حول كلية الطب البشري

نفتخر بما نقدمه للمجتمع والعالم

80

المنشورات العلمية

238

هيئة التدريس

7385

الطلبة

0

الخريجون

البرامج الدراسية

درجة ماجستير
تخصص طب الأسرة والمجتمع

قريباً...

التفاصيل
المقرر الدراسي
تخصص طب الأطفالPD480

A twelve week rotation. Five weeks at Tripoli children hospital, rotating in the inpatient and outpatient departments.One week at the pediatric department –Tajoura hospital. Five weeks at Tripoli medical center, one week at university.Emphasis is on acquiring skills, and medical knowledge to be able...

التفاصيل

من يعمل بـكلية الطب البشري

يوجد بـكلية الطب البشري أكثر من 238 عضو هيئة تدريس

staff photo

د. سعاد سالم منصور حشاد

استشاري طب اطفال وروماتيزوم رئيس قسم وحدة عامة مشرف عام التدريب للزمالة الليبية بمستشفي الاطفال والمقرر الابحاث بمجلس التخصصات الليبي المشرف العام علي منظمة البرنتو الاوروبية لروماتيزوم الاطفال في ليبيا

منشورات مختارة

بعض المنشورات التي تم نشرها في كلية الطب البشري

Co-Occurrence of Plasmid-Mediated AmpC β-Lactamase Activity Among Klebsiella pneumoniae and Escherichia Coli

Introduction: Extended-spectrum β-lactamases (ESBLs), including the AmpC type, are important mechanisms of resistance among Klebsiella pneumoniae and Escherichia coli isolates. Objective: The aim of the study was to investigate the occurrence of AmpC-type β-lactamase producers isolated from two hospitals in Tripoli, Libya. Methods: All clinical isolates (76 K. pneumoniae and 75 E. coli) collected over two years (2013-2014) were evaluated for susceptibility to a panel of antimicrobials and were analyzed phenotypically for the ESBL and AmpC phenotype using E-test and ESBL and AmpC screen disc test. Both ESBL and AmpC-positive isolates were then screened for the presence of genes encoding plasmid-mediated AmpC β-lactamases by polymerase chain reaction (PCR). Results: Of the K. pneumoniae and E. coli tested, 75% and 16% were resistant to gentamicin, 74% and 1.3% to imipenem, 71% and 12% to cefoxitin, 80% and 12% to cefepime, 69% and 22.6% to ciprofloxacin, respectively. None of the E. coli isolates were multidrug resistant compared with K. pneumoniae (65.8%). K. pneumoniae ESBL producers were significantly higher (85.5%) compared with (17.3%) E. coli isolates (P
Abdulaziz Zorgani, Abdulla Bashein(1-2017)
Publisher's website

Prevalence of H63D and C282Y mutations in hereditary hemochromatosis (HFE) gene in Tripoli region of Libya

Background and Aims: Hereditary hemochromatosis (HH) is an autosomal recessive disorder, characterized by increased intestinal absorption of iron. Excessive amount of iron accumulates in the liver, pancreas, and heart, etc., and eventually leading to organ failure due to iron toxicity and death if untreated. The most common causes of HH are the C282Y and H63D mutations in HFE gene. This study aimed to identify the prevalence of H63D and C282Y alleles among the Libyan population in Tripoli region and to compare the results with other published data. Materials and Methods: This study included 300 randomly selected unrelated Libyan male blood donors, aged between 18 and 50 years. In‑house hydrolysis probe real‑time polymerase chain reaction and high‑resolution melting analysis protocols were developed and employed as screening tools for H63D and C282Y genotyping, respectively, and direct DNA sequencing was used to confirm the results. Results: Seven subjects (2.33%) were detected as homozygous H63D mutation and 72 (24%) were detected as heterozygous, and only one subject was detected as a heterozygous C282Y mutant (0.33%) and no homozygous C282Y mutation was detected. Conclusion: In Libyans residing in Tripoli region, the allele frequency of C282Y was very rare and allele frequency of H63D was common arabic 17 English 89
Laila Mohamed Elghawi, Abdulla Bashein(7-2021)
Publisher's website

A comparative study of alkaline phosphatase level in serum of patients with end-stage renal disease, viral hepatitis (C) and (B)

Alkaline phosphatase (ALP) enzyme level, which is routinely measured at clinical laboratories, increases in end-stage renal disease (ESRD) and hepatitis patients. This study investigated the difference in ALP level among ESRD and hepatitis patients. ALP level was measured in sera of patients suffering from ESRD, HCV and HBV infections, as well as patients suffering from comorbidity of these diseases, then the obtained values of ALP level were statistically compared to a control group. The results of three-Way ANOVA revealed that the mean of ALP level increased significantly (P-value< 0.05) in all types of diseases compared to the control group, with the highest increase in case of ESRD patients infected with Hepatitis B and C. Also, it was found that the interaction of group-gender significantly (P-value< 0.05) altered ALP level in patients suffering from HCV or HBV infections, while the interaction of group-age, gender-age, group-gender-age were found not to significantly alter it. In conclusion, ESRD patients with HBV/HCV coinfection may have a higher risk of liver-related morbidity and mortality than ESRD or HBV or HCV patients. arabic 25 English 103
HA Alemam, A Bashein(1-2020)
Publisher's website